Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

LVTX

LVTX News

Newswire

07:48

XOMA Royalty Acquires LAVA Therapeutics, Completes $1.04 Cash Per Share Deal.

07:46

XOMA Royalty Completes Acquisition of LAVA Therapeutics, Adding Two Early-Stage Bispecific Antibodies to Portfolio

08:52

LAVA Therapeutics to Delist from Nasdaq After Successful Tender Offer

07:32

LAVA Therapeutics Receives 87% Tender Offer for Acquisition by XOMA Royalty.

07:39

XOMA Royalty acquires LAVA Therapeutics, completes Turnstone Biologics and HilleVax acquisitions.

View More

About LVTX

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More